Literature DB >> 2301514

Chlamydia trachomatis infection in pregnancy and effect of treatment on outcome.

G M Ryan1, T N Abdella, S G McNeeley, V S Baselski, D E Drummond.   

Abstract

The effect of Chlamydia trachomatis on pregnancy outcome and the effect of treatment of positive cervical cultures was studied by culturing 11,544 women for chlamydia at their first prenatal visit. Chlamydia culture was positive in 2433 (21.08%) and prevalence was related to age and race. Of the positive cultures, 1110 were classified as untreated. The untreated group demonstrated a significant increase in the incidence of premature rupture of the membranes and low birth weight and a decrease in survival when compared with either those with positive cultures who received treatment (N = 1323) or those with negative cultures (N = 9111). Screening of populations at high risk of chlamydia is recommended and treatment of chlamydia-positive patients may improve pregnancy outcome.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2301514     DOI: 10.1016/0002-9378(90)90815-o

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  35 in total

1.  Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-infected Pregnant Women and Adverse Infant Outcomes.

Authors:  Kristina Adachi; Jeffrey D Klausner; Jiahong Xu; Bonnie Ank; Claire C Bristow; Mariza G Morgado; D Heather Watts; Fred Weir; David Persing; Lynne M Mofenson; Valdilea G Veloso; Jose Henrique Pilotto; Esau Joao; Glenda Gray; Gerhard Theron; Breno Santos; Rosana Fonseca; Regis Kreitchmann; Jorge Pinto; Marisa M Mussi-Pinhata; Mariana Ceriotto; Daisy Maria Machado; Yvonne J Bryson; Beatriz Grinsztejn; Francisco I Bastos; George Siberry; Karin Nielsen-Saines
Journal:  Pediatr Infect Dis J       Date:  2016-08       Impact factor: 2.129

Review 2.  The challenges of collecting data on race and ethnicity in a diverse, multiethnic state.

Authors:  Bliss Kaneshiro; Olga Geling; Kapuaola Gellert; Lynnae Millar
Journal:  Hawaii Med J       Date:  2011-08

Review 3.  The role of urogenital tract infections in the etiology of preterm birth: a review.

Authors:  J Martius; T Roos
Journal:  Arch Gynecol Obstet       Date:  1996       Impact factor: 2.344

4.  Detection of endocervical anti-Chlamydia trachomatis immunoglobulin A in pregnant women by a rapid, 6-minute enzyme-linked immunosorbent assay: comparison with PCR and chlamydial antigen detection methods.

Authors:  S S Witkin; A M Bongiovanni; S R Inglis
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

5.  Maternal Chlamydia trachomatis infections and preterm birth:the impact of early detection and eradication during pregnancy.

Authors:  Alonzo T Folger
Journal:  Matern Child Health J       Date:  2014-10

6.  Periodic health examination, 1996 update: 2. Screening for chlamydial infections. Canadian Task Force on the Periodic Health Examination.

Authors:  H D Davies; E E Wang
Journal:  CMAJ       Date:  1996-06-01       Impact factor: 8.262

7.  Risk factors for genital chlamydial infection.

Authors:  Christine Navarro; Anne Jolly; Rama Nair; Yue Chen
Journal:  Can J Infect Dis       Date:  2002-05

8.  Young pregnant women's views on the acceptability of screening for chlamydia as part of routine antenatal care.

Authors:  Jade E Bilardi; Deborah L De Guingand; Meredith J Temple-Smith; Suzanne Garland; Christopher K Fairley; Sonia Grover; Euan Wallace; Jane S Hocking; Sepehr Tabrizi; Marie Pirotta; Marcus Y Chen
Journal:  BMC Public Health       Date:  2010-08-19       Impact factor: 3.295

9.  Treating chlamydial infections in pregnancy and preventing adverse birth outcomes.

Authors:  Paul C Adamson; Jeffrey D Klausner
Journal:  Lancet Infect Dis       Date:  2018-01-19       Impact factor: 25.071

10.  Epidemiological study of Chlamydia trachomatis infection in pregnant women in Hungary.

Authors:  T Nyári; J Deák; E Nagy; I Veréb; L Kovács; G Mészáros; H Orvos; I Berbik
Journal:  Sex Transm Infect       Date:  1998-06       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.